Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1957 1
1959 1
1961 1
1965 1
1970 1
1971 2
1972 2
1973 1
1974 2
1975 7
1977 3
1978 3
1979 5
1980 1
1981 10
1982 8
1983 6
1984 7
1985 5
1986 6
1987 6
1988 12
1989 11
1990 7
1991 12
1992 17
1993 9
1994 6
1995 7
1996 3
1997 7
1998 3
1999 7
2000 7
2001 3
2002 10
2003 7
2004 3
2005 1
2009 1
2010 1
2013 1
2014 2
2015 1
2018 1
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

220 results
Results by year
Filters applied: . Clear all
Page 1
Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial.
Raghu G, van den Blink B, Hamblin MJ, Brown AW, Golden JA, Ho LA, Wijsenbeek MS, Vasakova M, Pesci A, Antin-Ozerkis DE, Meyer KC, Kreuter M, Santin-Janin H, Mulder GJ, Bartholmai B, Gupta R, Richeldi L. Raghu G, et al. Among authors: mulder gj. JAMA. 2018 Jun 12;319(22):2299-2307. doi: 10.1001/jama.2018.6129. JAMA. 2018. PMID: 29800034 Free PMC article. Clinical Trial.
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study.
Raghu G, van den Blink B, Hamblin MJ, Brown AW, Golden JA, Ho LA, Wijsenbeek MS, Vasakova M, Pesci A, Antin-Ozerkis DE, Meyer KC, Kreuter M, Moran D, Santin-Janin H, Aubin F, Mulder GJ, Gupta R, Richeldi L. Raghu G, et al. Among authors: mulder gj. Lancet Respir Med. 2019 Aug;7(8):657-664. doi: 10.1016/S2213-2600(19)30172-9. Epub 2019 May 20. Lancet Respir Med. 2019. PMID: 31122893 Clinical Trial.
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.
Cavazzana-Calvo M, Payen E, Negre O, Wang G, Hehir K, Fusil F, Down J, Denaro M, Brady T, Westerman K, Cavallesco R, Gillet-Legrand B, Caccavelli L, Sgarra R, Maouche-Chrétien L, Bernaudin F, Girot R, Dorazio R, Mulder GJ, Polack A, Bank A, Soulier J, Larghero J, Kabbara N, Dalle B, Gourmel B, Socie G, Chrétien S, Cartier N, Aubourg P, Fischer A, Cornetta K, Galacteros F, Beuzard Y, Gluckman E, Bushman F, Hacein-Bey-Abina S, Leboulch P. Cavazzana-Calvo M, et al. Among authors: mulder gj. Nature. 2010 Sep 16;467(7313):318-22. doi: 10.1038/nature09328. Nature. 2010. PMID: 20844535 Free PMC article.
Acquiring orphans.
Rooswinkel R, Mulder GJ, van Deventer S. Rooswinkel R, et al. Among authors: mulder gj. Nat Biotechnol. 2014 Mar;32(3):213-6. doi: 10.1038/nbt.2836. Nat Biotechnol. 2014. PMID: 24727767 No abstract available.
Reply to letter to the editor.
de Ree H, van den Berg M, Brand T, Mulder GJ, Simons R, Veldhuijzen van Zanten B, Westerink RH. de Ree H, et al. Among authors: mulder gj. Neurotoxicology. 2015 Jan;46:167-8. doi: 10.1016/j.neuro.2014.12.014. Epub 2015 Jan 13. Neurotoxicology. 2015. PMID: 25595098 No abstract available.
Building for big pharma.
Giniatullina A, Boorsma M, Mulder GJ, van Deventer S. Giniatullina A, et al. Among authors: mulder gj. Nat Biotechnol. 2013 Apr;31(4):284-7. doi: 10.1038/nbt.2533. Nat Biotechnol. 2013. PMID: 23563416 No abstract available.
220 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page